Cargando…

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy

Angiogenesis has been targeted in retinopathies, psoriasis, and a variety of cancers (colon, breast, lung, and kidney). Among these tumour types, clear cell renal cell carcinomas (RCCs) are the most vascularized tumours due to mutations of the von Hippel Lindau gene resulting in HIF-1 alpha stabilis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilmi, Caroline, Guyot, Mélanie, Pagès, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195439/ https://www.ncbi.nlm.nih.gov/pubmed/22013509 http://dx.doi.org/10.1155/2012/162692

Ejemplares similares

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
por: Guyot, Mélanie, et al.
Publicado: (2016)

Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
por: Kimoto, Kenichi, et al.
Publicado: (2012)

The role of VEGF receptors in angiogenesis; complex partnerships
por: Cébe-Suarez, S., et al.
Publicado: (2006)

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2023)

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment
por: Tremolada, Gemma, et al.
Publicado: (2012)

Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology
por: Formica, María L., et al.
Publicado: (2021)

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
por: Prea, Selwyn M., et al.
Publicado: (2015)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Protein-Protein Interaction Inhibitor of SRPKs Alters the Splicing Isoforms of VEGF and Inhibits Angiogenesis
por: Li, Qingyun, et al.
Publicado: (2021)

Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis
por: Xu, Manhong, et al.
Publicado: (2022)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

VEGF-A splice variants bind VEGFRs with differential affinities
por: Mamer, Spencer B., et al.
Publicado: (2020)

Multiple Roles for VEGF in Non-Melanoma Skin Cancer: Angiogenesis and Beyond
por: Johnson, Kelly E., et al.
Publicado: (2012)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010)

How VEGF-A and its splice variants affect breast cancer development – clinical implications
por: Al Kawas, Hivin, et al.
Publicado: (2022)

Tumor refractoriness to anti-VEGF therapy
por: Ribatti, Domenico
Publicado: (2016)

Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
por: Penco-Campillo, Manon, et al.
Publicado: (2023)

Anti-VEGF Therapy and the Retina: An Update
por: Tah, Vikas, et al.
Publicado: (2015)

The Multiple Roles of EG-VEGF/PROK1 in Normal and Pathological Placental Angiogenesis
por: Alfaidy, Nadia, et al.
Publicado: (2014)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2018)

Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF
por: Ward, Claire, et al.
Publicado: (2010)

Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
por: Zahra, Fatema Tuz, et al.
Publicado: (2021)

Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms: A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
por: Nowak, Dawid G., et al.
Publicado: (2010)

Extracellular Vesicle Membrane-Associated Proteins: Emerging Roles in Tumor Angiogenesis and Anti-Angiogenesis Therapy Resistance
por: Ko, Song Yi, et al.
Publicado: (2020)

Anti-VEGF Cancer Therapy in Nephrology Practice
por: Izzedine, Hassan
Publicado: (2014)

Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers
por: Mthembu, Nonkululeko N, et al.
Publicado: (2017)

Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
por: Abou-Fayçal, Cherine, et al.
Publicado: (2017)

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
por: Ohta, Y, et al.
Publicado: (1999)

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
por: Thurston, G, et al.
Publicado: (2008)

Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations
por: Kampougeris, George, et al.
Publicado: (2013)

Retraction: Role of alternative splicing of VEGF-A in the development of atherosclerosis
por: Zhao, Naishi, et al.
Publicado: (2023)

The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
por: Ribatti, Domenico, et al.
Publicado: (2021)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
por: Yerramothu, Praveen
Publicado: (2018)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

The role of Anti-VEGF agents in treatment of neovascular glaucoma
por: Palfi (Salavat), Mădălina-Casiana, et al.
Publicado: (2022)

Angiogenesis versus arteriogenesis: neuropilin 1 modulation of VEGF signaling
por: Kofler, Natalie M., et al.
Publicado: (2015)

Loss of phospholipase D2 impairs VEGF-induced angiogenesis
por: Lee, Chang Sup, et al.
Publicado: (2016)

VEGF tips its hand in angiogenesis
por: Short, Ben
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_inu8d688og3cppnmdccnm362mo